Ligand Pharma (LGND) PT Raised to $237 at H.C. Wainwright

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. DOX
5. CRWD
6. CHKP
7. ON
8. HNGE
9. INSP
10. SPY

Go back to Ligand Pharma (LGND) PT Raised to $237 at H.C. Wainwright

Ligand Reports Fourth Quarter and Full Year 2019 Financial Results

February 6, 2020 4:01 PM EST

Conference Call and Webcast with Slides Begins at 4:30 p.m. Eastern Time Today

SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and 12 months ended December 31, 2019, and provided an operating forecast and program updates. Ligand management will host a conference call and webcast with accompanying slides today beginning at 4:30 p.m. Eastern time to discuss this announcement and answer questions.

Ligand made tremendous progress during 2019 in areas that will drive our future success, including new license agreements, outstanding revenue... More